A study to compare the effect of Bharangyadi syrup and Vasa avleha syrup in reducing Asthma symptoms in children

Randomized Comparative Controlled Clinical Study on the Efficacy of Bharangyadi Syrup in Intermittent Phase of Bronchial Asthma in Children - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/104149

Enrollment

Registered

2026-02-18

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J452- Mild intermittent asthma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of age group 5 to 10 years 2. Patient with the symptoms of Tamaka Swasa and cases of intermittent phase of Bronchial asthma 3. Patients will be recruited in the study after the assent procedure and written informed consent from the parent or guardian 4. Children of either gender, irrespective of caste, religion, and socio-economic status, will be taken

Exclusion criteria

Exclusion criteria: 1. All other types of swasa roga and other phases of asthma i.e. Mild persistent, Moderate persistent & severe persistent 2. Children with acute exacerbation or status asthmaticus who require emergency care 3. Presence of systemic illness like tuberculosis, Pneumonia, congenital heart disease, or other chronic pulmonary conditions like COPD, pulmonary fibrosis and pulmonary hypertension

Design outcomes

Primary

Measure	Time frame
1. To reduce severity and frequency of symptoms of Tamaka Swasa 2. To improve MPASS scoringTimepoint: Oth, 15th, 30th, 45th, 60th day	—

Secondary

Measure	Time frame
To improve peak expiratory flow monitoringTimepoint: 0th, 60th day	—

Countries

India

Contacts

Public ContactDr Anoop K Sasikumar

Parul Institute of Ayurved and Research

1.anoopks@gmail.com7559957065

Outcome results